Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

HealthLynked (HLYK) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for HealthLynked (HLYK) over the last 8 years, with Q3 2025 value amounting to $135820.0.

  • HealthLynked's Gains from Investment Securities rose 11741.98% to $135820.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $135820.0, marking a year-over-year increase of 11741.98%. This contributed to the annual value of $6.2 million for FY2024, which is 2088.22% up from last year.
  • HealthLynked's Gains from Investment Securities amounted to $135820.0 in Q3 2025, which was up 11741.98% from $6.1 million recorded in Q2 2025.
  • Over the past 5 years, HealthLynked's Gains from Investment Securities peaked at $62.3 million during Q3 2022, and registered a low of $7206.0 during Q4 2021.
  • In the last 5 years, HealthLynked's Gains from Investment Securities had a median value of $5.0 million in 2023 and averaged $9.2 million.
  • Per our database at Business Quant, HealthLynked's Gains from Investment Securities skyrocketed by 839853.36% in 2021 and then tumbled by 9866.91% in 2024.
  • Quarter analysis of 5 years shows HealthLynked's Gains from Investment Securities stood at $7206.0 in 2021, then soared by 863896.24% to $62.3 million in 2022, then plummeted by 91.82% to $5.1 million in 2023, then plummeted by 98.77% to $62469.0 in 2024, then soared by 117.42% to $135820.0 in 2025.
  • Its Gains from Investment Securities stands at $135820.0 for Q3 2025, versus $6.1 million for Q2 2025 and $6.2 million for Q1 2025.